TRV
34
-12
T
59
2
AME
50
-3
AA
48
-3
HON
62
10
USB
48
-2
PNW
50
-2
GOOG
59
-6
LOW
30
-9
R
66
-2
NI
75
2
EW
23
-2
EXC
53
3
ED
45
2
PBI
42
-4
LUV
56
4
ZTS
19
3
LB
28
-7
AMG
50
-2
DTE
56
2
TRV
34
-12
T
59
2
AME
50
-3
AA
48
-3
HON
62
10
USB
48
-2
PNW
50
-2
GOOG
59
-6
LOW
30
-9
R
66
-2
NI
75
2
EW
23
-2
EXC
53
3
ED
45
2
PBI
42
-4
LUV
56
4
ZTS
19
3
LB
28
-7
AMG
50
-2
DTE
56
2
Financhill
Back

Kymera Therapeutics 10K Form

Buy
77

KYMR
Kymera Therapeutics

Last Price:
$45.92
Seasonality Move:
30.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KYMR News And Ratings

See the #1 stock for the next 7 days that we like better than KYMR

KYMR Financial Statistics

Sales & Book Value

Annual Sales: $47.1M
Cash Flow: $-79.6M
Price / Cash Flow: 0
Annual Sales: $12.08
Price / Book: 3.8

Profitability

EPS (TTM): -3.10000
Net Income (TTM): $-240.9M
Gross Margin: --
Return on Equity: -30.8%
Return on Assets: -26.04%

Kymera Therapeutics Earnings Forecast

Key Kymera Therapeutics Financial Ratios

  • The Research & Development expenses have been 510.38% of Revenue.
  • The Net Earning history of KYMR is -475.57% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Kymera Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KYMR
Website: kymeratx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.49
Quick Ratio: 8.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KYMR Technical Analysis vs Fundamental Analysis

Buy
77
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy or a Sell?